A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Share this article:

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Sponsors and Collaborators
Kissei Pharmaceutical Co., Ltd.

Contact
Kissei Pharmaceutical Co., Ltd
rinsyousiken@pharm.kissei.co.jp

ClinicalTrials.gov Identifier
NCT01833494

Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Hyperphosphatemia Clinical Trials

Dose Finding Study to Treat High Phosphate Levels in the Blood

A look at the following clinical trial: Dose Finding Study to Treat High Phosphate Levels in the Blood.

Safety and Tolerability Study of MCI-196

A look at the following clinical trial: Safety and Tolerability Study of MCI-196.

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients ...

A look at the following clinical trial: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia.